Results 211 to 220 of about 128,263 (274)

A marker for Stevens–Johnson syndrome

open access: yesNature, 2004
Wen-Hung Chung   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: A multicenter observational study.

Journal of Allergy and Clinical Immunology: In Practice, 2022
BACKGROUND Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are fatal severe cutaneous adverse reactions, without consensus on the medical treatment. The use of systemic corticosteroids or intravenous immunoglobulin (IVIG) remains debatable.
Jing Zhang   +7 more
semanticscholar   +1 more source

UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

open access: yesJournal of Plastic, Reconstructive and Aesthetic Surgery, 2016
D Creamer, J Setterfield, C B Bunker
exaly   +2 more sources

Multidisciplinary care in Stevens-Johnson syndrome

open access: yesTherapeutic Advances in Chronic Disease, 2020
Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are potentially fatal mucocutaneous diseases that can involve many organ systems.
Swapna S Shanbhag   +2 more
exaly   +2 more sources

Stevens-Johnson Syndrome

Dimensions Of Critical Care Nursing, 1985
Stevens-Johnson syndrome is an extremely serious variation of erythema multiforme which can lead to major complications, critical illness, and death for children or adults. The characteristic rash and mucous membrane lesions are often accompanied by systemic toxicity which requires critical care.
R, Edwards, M, Ridder
  +7 more sources

Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).

The Medical clinics of North America, 2021
Severe cutaneous adverse reactions to medications (SCARs) include drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, toxic epidermal necrolysis, and acute generalized exanthematous pustulosis. They are all non-immunoglobulin
C. Owen, Jordan M. Jones
semanticscholar   +1 more source

Stevens-Johnson syndrome

European Journal of Pediatrics, 2007
A 13-year-old boy was brought to the emergency department (ED) with a generalized itchy rash of 2 days' duration. For the past 3 days, he had dry, itchy eyes with a purulent discharge (Figure 1) and nonbilious emesis 2 or 3 times per day, with some blood streaks in the vomitus on the third day of illness.
M H, de Ru, R N, Sukhai
openaire   +2 more sources

Stevens–Johnson syndrome after treatment with rituximab

open access: yesAnnals of Oncology, 2002
Rituximab is a chimeric mouse/human anti-CD20 antibody licensed for the treatment of low-grade non-Hodgkin’s lymphoma and has recently also been shown to have a role in the treatment of diffuse large B-cell lymphoma.
G Mead, A Lister
exaly   +2 more sources

Stevens‐Johnson Syndrome due to COVID‐19 vaccination

open access: yesClinical Case Reports (discontinued), 2021
As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.
Katalin Martits-Chalangari   +1 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy